What is the appropriate management and treatment plan for hyperthyroidism?

Management and Treatment of Hyperthyroidism

For newly diagnosed hyperthyroidism, initiate antithyroid drugs (ATDs) as first-line therapy, with methimazole preferred over propylthiouracil except in first trimester pregnancy or thyroid storm, and treat for 12-18 months before considering definitive therapy with radioactive iodine or thyroidectomy. 1, 2

Initial Diagnostic Workup

When hyperthyroidism is suspected, confirm with:

• TSH (suppressed) and free T4 or free T3 (elevated) to establish biochemical diagnosis 1
• TSH-receptor antibodies (TSH-R-Ab) to differentiate Graves' disease from other causes 2
• Thyroid ultrasound showing hypervascularity and hypoechogenicity suggests Graves' disease 2
• Radioactive iodine uptake scan if diagnosis remains unclear—high uptake indicates Graves' disease or toxic nodular goiter, low uptake suggests thyroiditis 1

Treatment Algorithm by Etiology

Graves' Disease (70% of cases)

Initial Medical Management:

• Start methimazole (MMI) 10-40 mg daily depending on severity of thyrotoxicosis 2
• Add beta-blocker (propranolol or atenolol) immediately for symptomatic relief of tachycardia, tremor, and anxiety 3
• Continue ATD for 12-18 months as standard course 1, 2
• Monitor thyroid function every 4-6 weeks initially, then every 2-3 months once stable 3

Predictors of Relapse After ATD Course: Patients at high risk for recurrence (approximately 50% overall) include those with: 1

• Age <40 years
• Free T4 ≥40 pmol/L at diagnosis
• TSH-binding inhibitory immunoglobulins >6 U/L
• Goiter size ≥WHO grade 2

For High-Risk Patients:

• Consider long-term low-dose MMI (5-10 years) which reduces recurrence to 15% compared to 50% with short-term treatment 1, 4
• Measure TSH-R-Ab at 12-18 months—if persistently elevated, continue MMI or proceed to definitive therapy 2

Definitive Treatment Options:

• Radioactive iodine (RAI) is effective but contraindicated with active/severe thyroid eye disease 5, 2
• Total thyroidectomy by high-volume surgeon for patients with compressive symptoms, concurrent thyroid cancer, pregnancy planning, or thyroid eye disease 6, 2

Toxic Nodular Goiter (16% of cases)

Preferred definitive treatment since spontaneous remission does not occur: 1

• Radioactive iodine therapy as first-line
• Thyroidectomy as alternative, particularly for large goiters with compressive symptoms 1
• ATDs used temporarily to achieve euthyroid state before definitive treatment 6

Thyroiditis (3% of cases)

Self-limited condition requiring supportive care: 3

• Beta-blocker for symptomatic relief (atenolol or propranolol) 3
• Monitor thyroid function every 2-3 weeks to detect transition to hypothyroidism 3
• Avoid ATDs—thyroiditis involves hormone release, not increased synthesis 3
• Steroids only for severe cases of subacute granulomatous thyroiditis 1

Special Populations

Pregnancy

• Switch from methimazole to propylthiouracil (PTU) when planning pregnancy and during first trimester due to methimazole teratogenicity 3, 2
• Use lowest effective ATD dose to maintain free T4 in high-normal range 3
• Monitor thyroid function every 4 weeks and adjust dosing 3
• Beta-blockers (propranolol) safe for symptom control until ATD takes effect 3
• Thyroidectomy reserved for ATD failure or severe adverse reactions, preferably in second trimester 3

Hyperthyroidism with Atrial Fibrillation

• Beta-blocker mandatory to control ventricular rate unless contraindicated 3
• Non-dihydropyridine calcium channel antagonists (diltiazem or verapamil) if beta-blockers contraindicated 3
• Normalize thyroid function before cardioversion as success rate is low during active thyrotoxicosis 3
• Antithrombotic therapy based on stroke risk factors (CHA2DS2-VASc score) 3

Subclinical Hyperthyroidism (TSH <0.1 mIU/L with normal free T4/T3)

• **Treat if TSH <0.1 mIU/L** in patients >65 years, or with cardiac disease, osteoporosis, or symptoms 3, 7
• Monitor every 3-6 months if TSH 0.1-0.45 mIU/L without risk factors 3, 8
• Treatment reduces atrial fibrillation risk when TSH normalized 7

Thyroid Eye Disease Considerations

• Avoid RAI with moderate-to-severe active thyroid eye disease 5
• If RAI necessary with mild active disease, give steroid prophylaxis (prednisone 0.3-0.5 mg/kg for 6 weeks) 5, 2
• ATDs or thyroidectomy preferred for moderate-to-severe thyroid eye disease 5

Monitoring During ATD Therapy

Essential monitoring parameters:

• Complete blood count at baseline and if fever/sore throat develops (agranulocytosis risk) 3, 6
• Liver function tests at baseline (hepatotoxicity risk) 6
• Thyroid function (TSH, free T4) every 4-6 weeks until stable, then every 2-3 months 3, 2

Thyroid Storm Management

Life-threatening emergency requiring immediate intervention: 6

• Propylthiouracil 500-1000 mg loading dose, then 250 mg every 4 hours (preferred over MMI due to peripheral T4-to-T3 conversion blockade) 6
• Iodine solution (SSKI) 5 drops every 6 hours given 1 hour after ATD 3
• Propranolol 1-2 mg IV every 10-15 minutes or high-dose oral 3, 6
• Hydrocortisone 100 mg IV every 8 hours 3
• Aggressive supportive care with cooling, hydration, and ICU monitoring 3, 6
• Definitive treatment (thyroidectomy) once stabilized 6

Common Pitfalls

• Do not use digoxin alone for rate control in acute hyperthyroidism—it is ineffective when adrenergic tone is high 3
• Do not perform cardioversion before achieving euthyroid state—recurrence risk is extremely high 3
• Do not give iodine before ATD in thyroid storm—it will worsen thyrotoxicosis by providing substrate for hormone synthesis 3
• Do not continue methimazole in first trimester pregnancy—switch to PTU to avoid aplasia cutis and other congenital anomalies 3, 2